Weekly round up from Life Sciences Industry.
Flex Pharma, Inc. (Nasdaq: FLKS) today announced that its stockholders approved all proposals relating to its planned merger with Salarius Pharmaceuticals, LLC at Flex Pharma’s special meeting of stockholders. Flex Pharma will file a Form 8-K to disclose detailed voting results for each proposal. Flex Pharma expects to complete the merger within the next week or two.
Date: July 15, 2019
Source: Business Wire
Sign up for DistilINFO e-Newsletters.
Empowering Patients to Improve Affordability.
HIMSS Insights Special Edition – APAC Digital Health Trendbarometer
Lantheus Completes Merger with Progenics
Analysis: November 2019 Health IT M&A Activity, Public Company Performance
Solid Biosciences Announces Stockholder Approval of Acquisition of AavantiBio
Tonix Pharmaceuticals Announces Agreement to Acquire Infectious Disease R&D Facility to Accelerate Development of Vaccines and Antiviral Drugs
9 Ways UX/UI Design Can Improve Digital Health Adoption for Seniors
Four Ways Technology is Helping Mental Health